On Monday, Anthropic formally filed its S-1 for a proposed Nasdaq listing under the ticker ANT, though it has not yet set either the number of shares or a price range.¹ The move puts the maker of Claude on course for one of the most consequential market debuts in years—less a routine flotation than a test of whether AI can become a durable public-company business.

The filing supplied striking evidence for the bullish case. Anthropic reported $16.3 billion in revenue for the first half of 2026, up from $1.2 billion a year earlier, while its operating loss narrowed to $693 million from $2.1 billion.² The company says AI could “rapidly accelerate scientific innovation,” boost growth and bring major disease cures within reach—but says those gains must be pursued while preventing the dangers of a technology moving at extraordinary speed.³

By the end of September, the enterprise footprint was substantial: more than 11,900 customers were spending at least $100,000 annually, including 1,900 spending $1 million or more. Yet the growth story comes with a balance-sheet-sized asterisk. Anthropic posted an $80.7 billion net loss in the first half, largely because of noncash convertible-debt accounting adjustments, and it cautioned that profitability may not be sustained.²

The central investor question is whether customer demand can outrun the cost of supplying it. Anthropic has disclosed hundreds of billions of dollars in compute and infrastructure arrangements; critics note that many customers pay according to usage while some capacity commitments require minimum payments regardless of actual use. Its five largest customers supplied roughly a quarter of revenue in the first nine months of 2026.⁴

Control is another dividing line. Seven co-founders, through a Founder LLC, will retain 50.1% of shareholder voting power after the listing—a structure Anthropic says protects its long-term safety mission, but one that leaves public investors with little practical influence.² Meanwhile, its prospectus warns advanced systems could pose “catastrophic or existential risks to humanity.”³

That makes the IPO a referendum on more than Anthropic’s valuation: it is a wager that safety, demand and cash generation can all keep pace with AI’s escalating bill.